<DOC>
	<DOCNO>NCT01739946</DOCNO>
	<brief_summary>The goal study compare protein marker urine patient without overactive bladder ( OAB ) InterStim® .</brief_summary>
	<brief_title>Urinary Biomarkers For Objective Measurement Of InterStim® Response In Over Active Bladder ( OAB ) Patients .</brief_title>
	<detailed_description>This study look change protein marker might reflect bladder symptom InterStim® implant .</detailed_description>
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<criteria>OAB subject ( n=10 Phase I n=10 Phase II ) Female Age 1875 year Clinical symptom OAB ( urgency frequency without urge incontinence ) least 3 6 month immediately first visit . At least 8 voids/day average 1 nocturnal void 3 consecutive day baseline bladder diary . InterStim® treatment naïve revise new lead Pelvic mass , pelvic prolapse , urinary retention , pelvic malignancy reveal physical examination/medical record review Implanted Programmable Generator ( IPG ) implanted/connected tined lead ( failed Stage I ) Revision IPG ( without replacement tin lead ) More one InterStim® device place ( undergoing bilateral stimulation ) Controls ( n=10 ) Inclusion : Female Age 1875 year Deny history OAB diagnosis symptom ( urgency frequency without urge incontinence ) American Urological Association ( AUA ) symptom score ≤4 Exclusion : History pelvic mass , prolapse , urinary retention , pelvic malignancy within last year</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>